Literature DB >> 33654935

An Optimized Method to Isolate Human Fibroblasts from Tissue for ex vivo Analysis.

Sara Waise1, Rachel Parker1, Matthew J J Rose-Zerilli1, David M Layfield1, Oliver Wood1, Jonathan West1,2, Christian H Ottensmeier1,3, Gareth J Thomas1, Christopher J Hanley1.   

Abstract

Despite their involvement in many physiological and pathological processes, fibroblasts remain a poorly-characterized cell type. Analysis of primary fibroblasts while maintaining their in vivo phenotype is challenging: standard methods for fibroblast isolation require cell culture in vitro, which is known to alter phenotypes. Previously-described protocols for the dissociation of primary tissues fail to extract sufficient numbers of fibroblasts, instead largely yielding immune cells. Here, we describe an optimized method for generating a fibroblast-enriched single-cell suspension from human tissues using combined mechanical and enzymatic dissociation. This allows analysis of ex vivo fibroblasts without the need for culture in vitro.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Fibroblasts; Lung; Stroma; Tissue disaggregation

Year:  2019        PMID: 33654935      PMCID: PMC7853986          DOI: 10.21769/BioProtoc.3440

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  31 in total

1.  Analysis of thymic stromal cell populations using flow cytometry.

Authors:  D H D Gray; A P Chidgey; R L Boyd
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

Review 2.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior.

Authors:  Alexis Desmoulière; Christelle Guyot; Giulio Gabbiani
Journal:  Int J Dev Biol       Date:  2004       Impact factor: 2.203

3.  On the origin of cancer-associated fibroblasts.

Authors:  Charlotte Anderberg; Kristian Pietras
Journal:  Cell Cycle       Date:  2009-05-25       Impact factor: 4.534

4.  Human primary lung endothelial cells in culture.

Authors:  Suzy A A Comhair; Weiling Xu; Lori Mavrakis; Micheala A Aldred; Kewal Asosingh; Serpil C Erzurum
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

Review 5.  From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.

Authors:  Charlotte Servais; Neta Erez
Journal:  J Pathol       Date:  2012-11-20       Impact factor: 7.996

Review 6.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

7.  Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation.

Authors:  Cécile Grange; Jason Létourneau; Marie-Andrée Forget; Jessica Godin-Ethier; Jocelyne Martin; Moishe Liberman; Mathieu Latour; Hugues Widmer; Jean-Baptiste Lattouf; Ciriaco A Piccirillo; Jean-François Cailhier; Réjean Lapointe
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

8.  An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.

Authors:  Jon G Quatromoni; Sunil Singhal; Pratik Bhojnagarwala; Wayne W Hancock; Steven M Albelda; Evgeniy Eruslanov
Journal:  J Leukoc Biol       Date:  2014-10-30       Impact factor: 4.962

9.  Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.

Authors:  Christopher J Hanley; Massimiliano Mellone; Kirsty Ford; Steve M Thirdborough; Toby Mellows; Steven J Frampton; David M Smith; Elena Harden; Cedric Szyndralewiez; Marc Bullock; Fergus Noble; Karwan A Moutasim; Emma V King; Pandurangan Vijayanand; Alex H Mirnezami; Timothy J Underwood; Christian H Ottensmeier; Gareth J Thomas
Journal:  J Natl Cancer Inst       Date:  2018-01-01       Impact factor: 13.506

10.  An optimised tissue disaggregation and data processing pipeline for characterising fibroblast phenotypes using single-cell RNA sequencing.

Authors:  Sara Waise; Rachel Parker; Matthew J J Rose-Zerilli; David M Layfield; Oliver Wood; Jonathan West; Christian H Ottensmeier; Gareth J Thomas; Christopher J Hanley
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.